Last reviewed · How we verify

NCT06314152

3-point With 1-point Mesh Fixation in TAPP for Inguinal Hernia

Completed NA Last updated 9 April 2026
What this trial tests

NA trial testing Lightweight mesh fixation in 3 points or 1 point in Inguinal Hernia in 351 participants. Completed in 10 October 2025.

Timeline
1 January 2023
Primary endpoint
10 October 2025
10 October 2025

Quick facts

Lead sponsorNanchong Central Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment351
Start date1 January 2023
Primary completion10 October 2025
Estimated completion10 October 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Nanchong Central Hospital

Who can join

Adults 18 to 80, any sex, with Inguinal Hernia or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was designed to compare the outcome of 3 point with 1 point lightweight mesh fixation in TAPP surgery for patients with inguinal hernia. The main outcome include seroma, chronic pain, recurrence, et al.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Inguinal Hernia

Currently open trials in the same condition.

Other Nanchong Central Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06314152.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing